Evidence map›Paper›PMID 39445054›Full record

ReviewAdolescent health, medicine and therapeutics2024

Advancing Immunization in Africa: Overcoming Challenges to Achieve the 2030 Global Immunization Targets.

Olalekan John Okesanya, Gbolahan Olatunji, Noah Olabode Olaleke, Mba Oluebube Mercy, Ayodele O Ilesanmi, Hassan Hakeem Kayode, Emery Manirambona, Mohamed Mustaf Ahmed, Bonaventure Michael Ukoaka, Don Eliseo Lucero-Prisno Iii

Abstract readReview
In one paragraph

Review in Adolescent health, medicine and therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Olalekan John OkesanyaDepartment of Public Health and Maritime Transport, University of Thessaly, Volos, Greece.ORCID 0000-0002-3809-4271
Gbolahan OlatunjiDepartment of Medicine and Surgery, University of Ilorin, Kwara, Nigeria.ORCID 0009-0002-2074-3277
Noah Olabode OlalekeObafemi Awolowo University Teaching Hospital Complex, Ile-Ife, Nigeria.ORCID 0000-0001-7070-276X
Mba Oluebube MercyDepartment of Physiotherapy, David Umahi Federal University Teaching Hospital, Uburu, Nigeria.ORCID 0009-0007-7355-349X
Ayodele O IlesanmiDepartment of Medical Laboratory Science, Oyo State Hospital Management Board, Oyo, Nigeria.ORCID 0000-0003-4429-5755
Hassan Hakeem KayodeDepartment of Medical Laboratory Science, Chrisland University, Abeokuta, Nigeria.ORCID 0000-0002-8508-3006
Emery ManirambonaCollege of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.ORCID 0000-0002-0579-3607
Mohamed Mustaf AhmedFaculty of Medicine and Health Sciences, SIMAD University, Mogadishu, Somalia.ORCID 0009-0006-5991-4052
Bonaventure Michael UkoakaDepartment of Internal Medicine, Asokoro District Hospital, Abuja, Nigeria.ORCID 0009-0000-9367-2612
Don Eliseo Lucero-Prisno IiiDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0002-2179-6365

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

African immunization programs are crucial in reducing the prevalence of infectious diseases and improving public health outcomes. This review provides an overview of the current status of immunization efforts in Africa, highlights key challenges, and offers recommendations to help the continent achieve the 2030 Global Immunization Goals. While progress has been made, significant challenges remain. For instance, the WHO African Region reports full immunization coverage at 56.5%, partial coverage at 35.1%, and zero immunization coverage at 8.4%. Between 2019 and 2021, approximately 67 million children in Africa did not receive routine vaccinations, with West and Central Africa particularly affected. DTP1 coverage remained stable at 80%, but DTP3 coverage saw a slight drop to 72% between 2021 and 2022. As of 2022, MCV1 coverage reached 69%, reflecting ongoing efforts against measles. Key barriers to vaccination include limited parental education, religious beliefs, inadequate healthcare systems, and vaccine hesitancy. Addressing these barriers requires community-driven approaches like door-to-door campaigns and mobile clinics. To reach the 2030 immunization targets, health systems must be strengthened, vaccine supply chains optimized, and financial resources-both domestic and international-expanded. The Immunization Agenda 2030 (IA2030) emphasizes data-driven decision-making, nation-ownership, and tailored strategies to overcome obstacles and raise immunization coverage among several demographic groups. Achieving these 2030 goals in Africa requires collaborative efforts to ensure equitable access to vaccines, address sociocultural challenges, and strengthen health system infrastructure.

Indexed as

Africaimmunityimmunizationvaccinationvaccine

Identifiers

PMID39445054
PMCPMC11498038

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.